Skip to main content
. Author manuscript; available in PMC: 2008 Mar 24.
Published in final edited form as: Alcohol Clin Exp Res. 2007 Dec 21;32(2):259–265. doi: 10.1111/j.1530-0277.2007.00575.x

Fig. 1.

Fig. 1

Consumption of 20% (v/v) ethanol (A) and blood ethanol concentrations (BECs) (B) following the 4-hour ethanol consumption test on day 4 of Experiment 1. Mice were given an intraperitoneal (i.p.) injection of the CRF1R antagonist CP-154,526 (0, 1, 3, 10 mg/kg) 30 minutes before access to ethanol. There were no significant differences between treatment groups. All values are means ± SEM.